• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性和转移性淋巴结甲状腺乳头状癌中钠/碘同向转运体表达与I131全身扫描摄取的关系。

Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.

作者信息

Lee S J, Choi K-C, Han J P, Park Y-E, Choi M G

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, ChunCheon Sacred Heart Hospital, Gyo-Dong 153, ChunCheon-Si, Kangwon-Do 200-704, Republic of Korea.

出版信息

J Endocrinol Invest. 2007 Jan;30(1):28-34. doi: 10.1007/BF03347392.

DOI:10.1007/BF03347392
PMID:17318019
Abstract

The aim of the present study was to evaluate total and membranous Na+/I- symporter (NIS) expressions in papillary thyroid carcinoma (PTC) tissue, correlation of NIS expression between primary and metastatic lymph node (LN) PTC tissues, and relationship of NIS expression with I131 whole body scan (WBS) uptake between primary and metastatic LN PTC tissues by analyzing 17 pairs of primary and metastatic LN PTC tissues. Staining positivity was calculated, and staining intensity was graded as negative (0), weak (1+), moderate (2+) and strong (3+). In primary PTC tissues, positivities and intensities of normal cells were higher than those of carcinoma cells but had no correlation with those in matched metastatic LN PTC tissues. In classic type, positivities, intensities and membranous intensities (mIS) were correlated between primary and matched metastatic LN PTC tissues. In patients aged younger than 45 yr, positivities and intensities in primary PTC tissues had correlation with those in matched metastatic LN PTC tissues. Positivities, intensities, mIS and pathological subtype of carcinoma cells in primary PTC tissues were not correlated with age, tumor size, TNM stage, MACIS score and thyroglobulin (Tg) levels at the time of I131 WBS. Sensitivity, specificity, as well as positive and negative predicted values of mIS in patients with I131 WBS uptake were 69.2, 75, 90 and 42.9% in primary PTC tissues, and 92.3, 100, 100 and 80% in metastatic LN PTC tissues. The results of mIS taken either as positive or negative were correlated with those of I131 WBS after controlling for age. Our results demonstrate that PTC tissues have altered total and membranous NIS expressions, suggesting that NIS expression in primary PTC tissues may predict NIS expression and I131 WBS uptake in matched metastatic LN PTC tissues.

摘要

本研究旨在通过分析17对原发性和转移性淋巴结(LN)甲状腺乳头状癌(PTC)组织,评估PTC组织中总钠/碘同向转运体(NIS)和膜性NIS的表达、原发性和转移性LN PTC组织之间NIS表达的相关性,以及原发性和转移性LN PTC组织中NIS表达与I131全身扫描(WBS)摄取的关系。计算染色阳性率,并将染色强度分为阴性(0)、弱阳性(1+)、中度阳性(2+)和强阳性(3+)。在原发性PTC组织中,正常细胞的阳性率和强度高于癌细胞,但与配对的转移性LN PTC组织中的阳性率和强度无相关性。在经典型中,原发性和配对的转移性LN PTC组织之间的阳性率、强度和膜性强度(mIS)具有相关性。在年龄小于45岁的患者中,原发性PTC组织中的阳性率和强度与配对的转移性LN PTC组织中的阳性率和强度具有相关性。原发性PTC组织中癌细胞的阳性率、强度、mIS和病理亚型与I131 WBS时的年龄、肿瘤大小、TNM分期、MACIS评分和甲状腺球蛋白(Tg)水平无关。I131 WBS摄取患者中,原发性PTC组织mIS的敏感性、特异性以及阳性和阴性预测值分别为69.2%、75%、

相似文献

1
Relationship of sodium/iodide symporter expression with I131 whole body scan uptake between primary and metastatic lymph node papillary thyroid carcinomas.原发性和转移性淋巴结甲状腺乳头状癌中钠/碘同向转运体表达与I131全身扫描摄取的关系。
J Endocrinol Invest. 2007 Jan;30(1):28-34. doi: 10.1007/BF03347392.
2
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.钠/碘同向转运体表达与分化型甲状腺癌复发病灶中¹³¹I摄取之间的关系
Eur J Nucl Med. 2001 May;28(5):639-45.
3
Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.甲状腺微小乳头状癌隐匿性颈转移淋巴结中钠碘同向转运体和促甲状腺激素受体的表达。
Ann Surg Oncol. 2012 Mar;19(3):990-5. doi: 10.1245/s10434-011-2047-y. Epub 2011 Aug 31.
4
Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.人钠碘同向转运体mRNA在原发性和转移性甲状腺乳头状癌中的表达
Thyroid. 2000 Mar;10(3):211-7. doi: 10.1089/thy.2000.10.211.
5
Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.利用18F-2-脱氧葡萄糖正电子发射断层扫描和Tc-99m四膦酸盐单光子发射计算机断层扫描检测甲状腺乳头状癌颈部转移淋巴结
Anticancer Res. 2003 May-Jun;23(3C):2973-6.
6
Comparison of 18F-fluorodeoxyglucose uptake with the expressions of glucose transporter type 1 and Na+/I- symporter in patients with untreated papillary thyroid carcinoma.未治疗的甲状腺乳头状癌患者中 18F-氟代脱氧葡萄糖摄取与葡萄糖转运蛋白 1 和 Na+/I- 同向转运体表达的比较。
Endocr Res. 2013;38(2):77-84. doi: 10.3109/07435800.2012.713426. Epub 2012 Aug 13.
7
Sodium-iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas.钠-碘同向转运体(NIS)基因在甲状腺乳头状癌淋巴结转移灶中的表达
Eur J Endocrinol. 2000 Nov;143(5):623-7. doi: 10.1530/eje.0.1430623.
8
Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.缺碘人群甲状腺癌中钠/碘同向转运体的分布:一项免疫组织化学研究
World J Surg. 2007 Sep;31(9):1737-1742. doi: 10.1007/s00268-007-9156-6.
9
Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression.甲状腺乳头状癌的肾转移:碘化钠转运体表达的研究
Thyroid. 2001 Aug;11(8):795-804. doi: 10.1089/10507250152484664.
10
Impact factors for the outcome of the first I radiotherapy in patients with papillary thyroid carcinoma after total thyroidectomy.全甲状腺切除术后乳头状甲状腺癌患者首次碘放疗结局的影响因素。
Ann Nucl Med. 2019 Mar;33(3):177-183. doi: 10.1007/s12149-018-01321-w. Epub 2018 Dec 4.

引用本文的文献

1
Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.甲状腺乳头癌和低分化甲状腺癌的碘摄取能力可通过免疫组织化学和分子研究来预测。
Eur Thyroid J. 2023 Jul 28;12(4):e230099. doi: 10.1530/ETJ-23-0099.
2
Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer.海藻和碘摄入量与 SLC5A5 rs77277498 与甲状腺癌的关系。
Endocrinol Metab (Seoul). 2022 Jun;37(3):513-523. doi: 10.3803/EnM.2021.1306. Epub 2022 May 24.
3
A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform.

本文引用的文献

1
Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.甲状腺功能减退的良性和恶性甲状腺肿瘤中钠/碘同向转运体表达的转录和转录后改变的证据。
Am J Pathol. 2004 Jul;165(1):25-34. doi: 10.1016/S0002-9440(10)63272-5.
2
Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas.甲状腺癌中甲状腺球蛋白碘化缺失与参与碘代谢的甲状腺特异性蛋白表达之间的相关性。
J Clin Endocrinol Metab. 2003 Oct;88(10):4977-83. doi: 10.1210/jc.2003-030586.
3
一种新型的微流控装置能够维持功能性甲状腺癌标本的体外功能,为新的药物筛选平台提供了可能。
BMC Cancer. 2019 Mar 22;19(1):259. doi: 10.1186/s12885-019-5465-z.
4
The Role of the NIS (SLC5A5) Gene in Papillary Thyroid Cancer: A Systematic Review.钠-碘同向转运体(SLC5A5)基因在甲状腺乳头状癌中的作用:一项系统评价
Int J Endocrinol. 2018 Nov 14;2018:9128754. doi: 10.1155/2018/9128754. eCollection 2018.
5
NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features.甲状腺肿瘤中的NIS表达、与预后及临床病理和分子特征的关系。
Endocr Connect. 2018 Jan;7(1):78-90. doi: 10.1530/EC-17-0302.
6
Sorafenib treatment of radioiodine-refractory advanced thyroid cancer in daily clinical practice: a cohort study from a single center.索拉非尼在日常临床实践中治疗放射性碘难治性晚期甲状腺癌:一项单中心队列研究
Endocrine. 2015 Aug;49(3):726-34. doi: 10.1007/s12020-014-0481-x. Epub 2014 Nov 21.
7
Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy.利用 Na/I 同向转运体作为报告基因在活体动物中可视化基因表达:在生物治疗中的应用。
Br J Pharmacol. 2010 Feb;159(4):761-71. doi: 10.1111/j.1476-5381.2009.00412.x. Epub 2009 Oct 8.
Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections.
利用高密度组织微阵列和传统切片技术研究甲状腺癌、乳腺癌及其他癌症中钠/碘同向转运体的免疫组织化学特征。
J Clin Endocrinol Metab. 2003 Apr;88(4):1880-8. doi: 10.1210/jc.2002-021544.
4
Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.良性无功能性甲状腺腺瘤的特征是细胞膜靶向缺陷或钠碘同向转运体蛋白表达降低。
J Clin Endocrinol Metab. 2002 Jan;87(1):352-7. doi: 10.1210/jcem.87.1.8173.
5
Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.转移性分化型甲状腺癌中碘化钠转运体表达的免疫组织化学分析:与放射性碘摄取的相关性
J Clin Endocrinol Metab. 2001 Nov;86(11):5627-32. doi: 10.1210/jcem.86.11.8048.
6
Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.人甲状腺癌细胞系及人甲状腺肿瘤中pendrin和钠/碘同向转运体基因的表达模式
Eur J Endocrinol. 2001 Aug;145(2):129-35. doi: 10.1530/eje.0.1450129.
7
Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases.快速通讯:大量甲状腺癌病例样本中钠/碘同向转运体(NIS)主要在细胞内过表达
J Clin Endocrinol Metab. 2001 Jun;86(6):2697-700. doi: 10.1210/jcem.86.6.7746.
8
Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.钠/碘同向转运体表达与分化型甲状腺癌复发病灶中¹³¹I摄取之间的关系
Eur J Nucl Med. 2001 May;28(5):639-45.
9
Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin.促甲状腺激素对钠/碘同向转运体的转录后调控
J Biol Chem. 2001 Jun 15;276(24):21458-63. doi: 10.1074/jbc.M100561200. Epub 2001 Apr 4.
10
Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas.分化型人类甲状腺癌中钠/碘同向转运体基因突变的缺失
Thyroid. 2001 Jan;11(1):37-9. doi: 10.1089/10507250150500649.